Latest filing published 15 Sept 2022 for Codiak BioSciences, Inc., €7.5M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
ARCH Venture Fund VIII, L.P.: trading record in brief
This profile gathers the share dealings of ARCH Venture Fund VIII, L.P. across 5 companies, led by Codiak BioSciences, Inc., Metacrine, Inc. and Scholar Rock Holding Corp. Over a trading history stretching from 12 December 2017 to 13 September 2022, the count stands at 22 filings.
On the market, this insider has only ever bought: 4 purchases, €13.0M in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2022 to date brings 1 purchase and no sales.
Half of the purchases are above €2.7M and half below. On 3 out of 4 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 15 September 2022: an open-market purchase of €7.5M, in Codiak BioSciences, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to ARCH Venture Fund VIII, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000,000 shares@ US$1.50100.0% of flowCommon SotckSEC:0001062993-22-019586:0Canonical exit: 12 Dec 2022 (T+90)
- 235,000 shares@ US$15.0028.6% of flowCommon StockSEC:0000899243-20-028809:5Canonical exit: 14 Jan 2021 (T+90)
- 1,784,572 sharesCommon StockSEC:0000899243-20-028809:0
- 831,521 sharesCommon StockSEC:0000899243-20-028809:1
- 420,368 sharesCommon StockSEC:0000899243-20-028809:2
- 326,953 sharesCommon StockSEC:0000899243-20-028809:3
- 191,721 sharesCommon StockSEC:0000899243-20-028809:4
- 138,734 sharesCommon StockSEC:0001209191-20-051402:4
- 210,000 shares@ US$13.0091.3% of flowCommon StockSEC:0001209191-20-051402:3Canonical exit: 17 Dec 2020 (T+90)
- 1,960,784 sharesCommon StockSEC:0001209191-20-051402:0
- 472,251 sharesCommon StockSEC:0001209191-20-051402:1
- 138,734 sharesCommon StockSEC:0001209191-20-051402:2
- 20,000 shares@ US$13.008.7% of flowCommon StockSEC:0001209191-20-051402:5Canonical exit: 17 Dec 2020 (T+90)
- 400,000 shares0Common StockSEC:0001012975-19-000551:0
- 300,001 shares0Common StockSEC:0001012975-19-000390:0
- 437,859 sharesCommon StockSEC:0001104659-18-037317:0
- 634,579 sharesCommon StockSEC:0001104659-18-037317:1
- 551,807 sharesCommon StockSEC:0001104659-18-037317:2
- 719,559 sharesCommon StockSEC:0001104659-18-037317:3
- 293,813 sharesCommon StockSEC:0001104659-18-037317:4
- 6,068,695 shares0Common StockSEC:0000899243-18-009446:0
- 10,756,249 sharesCommon StockSEC:0001209191-17-065251:0
22 of 22 declarations
